S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009
- Sponsor:
- Byron Dorgan
- Summary:
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
Pharmaceutical Market Access and Drug Safety Act of 2009
S. 525 — 111th Congress (2009–2010)
- Keywords
- FDA, Cosmetics, Pharmacueticals
- Summary
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Other Titles
- Pharmaceutical Market Access and Drug Safety Act of 2009
- Sponsor
- Byron Dorgan
- Co-Sponsors
- Daniel Inouye
- Amy Klobuchar
- Patrick Leahy
- Jeff Bingaman
- Susan Collins
- Edward Kennedy
- Barbara Boxer
- Debbie Ann Stabenow
- Russell Feingold
- John McCain
- John Kerry
- Richard Durbin
- Carl Levin
- Herbert Kohl
- Arlen Specter
- Blanche Lincoln
- Mark Begich
- John Thune
- Sherrod Brown
- Charles Grassley
- Olympia Snowe
- Robert Casey
- Jeanne Shaheen
- Claire McCaskill
- Bill Nelson
- Bernard Sanders
- Kent Conrad
- Jon Tester
- Tim Johnson
- Subjects
- Health
- Administrative law and regulatory procedures
- Administrative remedies
- Asia
- Australia
- Business records
- Canada
- Civil actions and liability
- Consumer affairs
- Consumer credit
- Contracts and agency
- Department of Health and Human Services
- Europe
- European Union
- Evidence and witnesses
- Federal Trade Commission (FTC)
- Federal preemption
- Food and Drug Administration (FDA)
- Fraud offenses and financial crimes
- Government investigations
- Health information and medical records
- Intellectual property
- Intergovernmental relations
- Internet and video services
- Japan
- Marketing and advertising
- Medical education
- Medical tests and diagnostic methods
- New Zealand
- Oceania
- Prescription drugs
- Product safety and quality
- Retail and wholesale trades
- Switzerland
- Trade restrictions
- User charges and fees
- Related Bills
- Major Actions
Introduced 3/04/2009 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/04/2009 3/04/2009 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 3/05/2009 Sponsor introductory remarks on measure. (CR S2780-2781) Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
supported this bill
| Physicians | $8,606,811 |
| Teachers unions | $1,082,925 |
| Farm organizations & cooperatives | $403,291 |
| Small business associations | $323,862 |
| Elderly issues/Social Security (split) | |
| $10,416,889 |
opposed this bill
| Lobbyists & Public Relations | $21,978,521 |
| Other physician specialists | $8,501,473 |
| Women's issues | $7,635,330 |
| Pharmaceutical manufacturing | $6,656,197 |
| Republican/Conservative | $5,504,945 |
| Accident & health insurance | $3,317,115 |
| HMOs | $2,326,215 |
| Health, Education & Human Resources | $1,744,493 |
| Health care services | $1,665,806 |
| Non-profit foundations | $1,458,648 |
| Biotech products & research | $1,156,759 |
| Minority/Ethnic Groups | $1,152,022 |
| Home care services | $1,093,629 |
| Drug stores | $1,055,288 |
| Pharmacists | $620,091 |
| Health & welfare policy | $399,600 |
| Health professionals | $206,025 |
| Manufacturing | $194,540 |
| Military | $177,633 |
| Elderly issues/Social Security (split) | |
| $66,844,330 |
Interest groups that opposed this bill gave 6.4 times as much as interest groups that supported this bill
Contributions data source: OpenSecrets.org
